Article Versions Notes

Yusenko MV, Biyanee A, Frank D, Köhler LHF, Andersson MK, Khandanpour C, Schobert R, Stenman G, Biersack B, Klempnauer K-H. Bcr-TMP, a Novel Nanomolar-Active Compound That Exhibits Both MYB- and Microtubule-Inhibitory Activity. Cancers. 2022; 14(1):43. https://doi.org/10.3390/cancers14010043

Yusenko, Maria V., Abhiruchi Biyanee, Daria Frank, Leonhard H. F. Köhler, Mattias K. Andersson, Cyrus Khandanpour, Rainer Schobert, Göran Stenman, Bernhard Biersack, and Karl-Heinz Klempnauer. 2022. "Bcr-TMP, a Novel Nanomolar-Active Compound That Exhibits Both MYB- and Microtubule-Inhibitory Activity" Cancers 14, no. 1: 43. https://doi.org/10.3390/cancers14010043

Yusenko, M. V., Biyanee, A., Frank, D., Köhler, L. H. F., Andersson, M. K., Khandanpour, C., Schobert, R., Stenman, G., Biersack, B., & Klempnauer, K.-H. (2022). Bcr-TMP, a Novel Nanomolar-Active Compound That Exhibits Both MYB- and Microtubule-Inhibitory Activity. Cancers, 14(1), 43. https://doi.org/10.3390/cancers14010043